<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>Liver Disease Information</title><link href="liverdiseaseinfo.com" rel="alternate"></link><id>liverdiseaseinfo.com</id><updated>2010-08-25T14:56:23Z</updated><entry><title>Richie Hayward, co-founder of Little Feat, dies</title><link href="http://liverdiseaseinfo.com/liver-diseases/richie-hayward-cofounder-feat-dies-1019261a" rel="alternate"></link><updated>2010-08-13T10:30:10Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-08-13:/liver-diseases/richie-hayward-cofounder-feat-dies-1019261a</id><summary type="html">&lt;div id="subtitle"&gt;Richie &lt;a title="Hayward" href="/topic/Hayward" &gt;Hayward&lt;/a&gt;, co-founder of &lt;a title="Little Feat (Band)" href="/topic/Little+Feat+(Band)" &gt;band Little Feat&lt;/a&gt;, dies of liver cancer&lt;/div&gt;&lt;div&gt;&lt;p&gt;Little Feat co-founder &lt;a title="Richie Hayward" href="/topic/Richie+Hayward" &gt;Richie Hayward&lt;/a&gt; has died. He was 64. Band publicist &lt;a title="Bridget Nolan" href="/topic/Bridget+Nolan" &gt;Bridget Nolan&lt;/a&gt; says the drummer had been suffering from liver cancer and died Thursday at a ho...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Hayward"></category><category term="Little Feat (Band)"></category><category term="Lowell George"></category><category term="Bridget Nolan"></category><category term="Richie Hayward"></category></entry><entry><title>Vertex: telaprevir could shorten hep C treatment</title><link href="http://liverdiseaseinfo.com/liver-diseases/vertex-telaprevir-shorten-hep-treatment-1016013a" rel="alternate"></link><updated>2010-08-25T14:56:23Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-08-25:/liver-diseases/vertex-telaprevir-shorten-hep-treatment-1016013a</id><summary type="html">&lt;div id="subtitle"&gt;Vertex says patients who responded quickly to hepatitis C drug can finish treatment sooner&lt;/div&gt;&lt;div&gt;&lt;p&gt;&lt;a title="Vertex Pharmaceuticals Inc." href="/topic/Vertex+Pharmaceuticals+Inc." &gt;Vertex Pharmaceuticals Inc.&lt;/a&gt; said Tuesday that a study showed some patients who take its hepatitis C drug candidate telaprevir may be able to complete their treatment sooner. Vertex said patients who responded quickly to treatment with telaprevir had better results after 24 weeks of therapy ...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Clinical Trials"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Vertex Pharmaceuticals Inc."></category></entry><entry><title>APNewsBreak: 4 positive tests of St. Louis vets</title><link href="http://liverdiseaseinfo.com/liver-diseases/apnewsbreak-4-positive-tests-st-louis-vets-1006234a" rel="alternate"></link><updated>2010-07-30T08:00:11Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-07-30:/liver-diseases/apnewsbreak-4-positive-tests-st-louis-vets-1006234a</id><summary type="html">&lt;div id="subtitle"&gt;APNewsBreak: 4 positive tests of vets treated at &lt;a title="St. Louis" href="/topic/St.+Louis" &gt;St. Louis&lt;/a&gt;, but illness sources undetermined&lt;/div&gt;&lt;div&gt;&lt;p&gt;Four veterans treated at the St. Louis VA Medical Center's dental clinic have tested positive for hepatitis, but further testing is needed to determine if inadequately sterilized dental equipment is to blame. The &lt;a title="U.S. Department of Veterans Affairs" href="/topic/U.S.+Department+of+Veterans+Affairs" &gt;Veterans Admin...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="The Associated Press"></category></entry><entry><title>LASVEGASSUN.COM</title><link href="http://liverdiseaseinfo.com/liver-diseases/lasvegassuncom-956793a" rel="alternate"></link><updated>2010-06-08T02:15:31Z</updated><author><name>Las Vegas Sun</name></author><id>tag:liverdiseaseinfo.com,2010-06-08:/liver-diseases/lasvegassuncom-956793a</id><summary type="html">&lt;div id="subtitle"&gt;THE BEST OF OUR EXCLUSIVE STORIES, PHOTOGRAPHY, VIDEO AND MULTIMEDIA &amp;#8212; EVERY DAY.&lt;/div&gt;&lt;div&gt;&lt;p&gt;10 minutes courtside&lt;/p&gt;&lt;p&gt; Visit lasvegassun.com/rebels to read &lt;a title="UNLV Rebels (Basketball)" href="/topic/UNLV+Rebels+(Basketball)" &gt;UNLV&lt;/a&gt; beat writer Ryan Greene&amp;#213;s weekly installment of &amp;#210;10 minutes with ...&amp;#211; This week, he chats with Rebels junior forward &lt;a title="Chace Stanback" href="/topic/Chace+Stanback" &gt;Chace Stanback&lt;/a&gt;.&lt;/p&gt;&lt;p&gt; Doctor indicted...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="American Civil Liberties Union"></category><category term="Las Vegas Sun"></category><category term="Dipak Desai"></category><category term="Chace Stanback"></category><category term="UNLV Rebels (Basketball)"></category></entry><entry><title>Australian police probe hepatitis cluster at abortion clinic</title><link href="http://liverdiseaseinfo.com/liver-diseases/australian-police-probe-hepatitis-cluster-abortion-clinic-949634a" rel="alternate"></link><updated>2010-05-31T12:16:03Z</updated><author><name>AFP Global Edition</name></author><id>tag:liverdiseaseinfo.com,2010-05-31:/liver-diseases/australian-police-probe-hepatitis-cluster-abortion-clinic-949634a</id><summary type="html">&lt;div&gt;&lt;p&gt;Australian police were Monday investigating whether women treated at an abortion clinic were deliberately infected with hepatitis C, as the number of cases linked to the centre rose to 22. Police said they were probing how patients at the &lt;a title="Melbourne" href="/topic/Melbourne" &gt;Melbourne&lt;/a&gt; medical centre, which performs late-term abortions, contracted the disease, which is transmitted via blood and can develop into cirrhosis and liver cancer. "Detectives are working to discover w...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Abortion"></category><category term="Croydon"></category><category term="John Carnie"></category></entry><entry><title>FDA puts liver damage warning on weight loss pill</title><link href="http://liverdiseaseinfo.com/liver-diseases/fda-puts-liver-damage-warning-weight-loss-pill-945349a" rel="alternate"></link><updated>2010-05-26T10:45:38Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-05-26:/liver-diseases/fda-puts-liver-damage-warning-weight-loss-pill-945349a</id><summary type="html">&lt;div id="subtitle"&gt;FDA warns weight loss drug may cause liver damage in rare cases&lt;/div&gt;&lt;div&gt;&lt;p&gt;Federal health officials are warning consumers that the weight loss pill alli may cause severe liver damage in rare cases. The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; says it has added a warning about the risk to the label of the drug, which is sold over-the-counter by &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKli...</summary><category term="Weight Loss"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Body Weight"></category></entry><entry><title>Vertex hep C drug achieves 75 pct cure rate: study</title><link href="http://liverdiseaseinfo.com/liver-diseases/vertex-hep-drug-achieves-75-pct-cure-rate-study-944409a" rel="alternate"></link><updated>2010-05-25T14:30:12Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-05-25:/liver-diseases/vertex-hep-drug-achieves-75-pct-cure-rate-study-944409a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A closely watched experimental hepatitis C treatment being developed by &lt;a title="Vertex Pharmaceuticals Inc." href="/topic/Vertex+Pharmaceuticals+Inc." &gt;Vertex Pharmaceuticals Inc&lt;/a&gt; led to a 75 percent cure rate in a pivotal late-stage trial of previously untreated patients, the company said on Tuesday. The results from the first Phase III study of telaprevir were roughly in line with expectations. ...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Vertex Pharmaceuticals Inc."></category><category term="Deena Beasley"></category></entry><entry><title>Sex hormone explains higher liver cancer risk in men</title><link href="http://liverdiseaseinfo.com/liver-diseases/sex-hormone-explains-higher-liver-cancer-risk-men-938981a" rel="alternate"></link><updated>2010-05-19T20:00:19Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-05-19:/liver-diseases/sex-hormone-explains-higher-liver-cancer-risk-men-938981a</id><summary type="html">&lt;div&gt;&lt;p&gt;HONG KONG (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Male sex hormones may explain why men who suffer from the hepatitis B liver disease are more likely to develop liver cancer than women, researchers in &lt;a title="Taiwan" href="/topic/Taiwan" &gt;Taiwan&lt;/a&gt; have found. In a paper published in Science Translational Medicine on Wednesday, the researchers said hepatitis B viruses attach themselves to receptors of the male sex hormone androgen before going on ...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Reuters Group plc"></category><category term="East Asia"></category><category term="Taiwan"></category><category term="Tainan City"></category><category term="Tan Ee Lyn"></category><category term="Ming-Heng Wu"></category><category term="Institute of Basic Medical Sciences"></category><category term="National Cheng Kung University"></category></entry><entry><title>Teva, Baxter ordered to pay $500 million in Hep C case</title><link href="http://liverdiseaseinfo.com/liver-diseases/teva-baxter-ordered-pay-500-million-hep-case-927699a" rel="alternate"></link><updated>2010-05-07T17:15:36Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-05-07:/liver-diseases/teva-baxter-ordered-pay-500-million-hep-case-927699a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="Teva Pharmaceutical Industries Ltd." href="/topic/Teva+Pharmaceutical+Industries+Ltd." &gt;Teva Pharmaceutical Industries&lt;/a&gt; and &lt;a title="Baxter Healthcare Services" href="/topic/Baxter+Healthcare+Services" &gt;Baxter Healthcare Services&lt;/a&gt; on Friday were ordered to pay a combined $500 million in punitive damages to a &lt;a title="Nevada" href="/topic/Nevada" &gt;Nevada&lt;/a&gt; man who contracted Hepatiti...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Clark County"></category><category term="Medical Imaging and Diagnostics"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Robert Eglet"></category><category term="Henry Chanin"></category><category term="Steve Eder"></category><category term="Baxter Healthcare Services"></category></entry><entry><title>Bollywood star Bachchan says has cirrhosis</title><link href="http://liverdiseaseinfo.com/liver-diseases/bollywood-star-bachchan-cirrhosis-916087a" rel="alternate"></link><updated>2010-04-26T12:00:32Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-26:/liver-diseases/bollywood-star-bachchan-cirrhosis-916087a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Mumbai" href="/topic/Mumbai" &gt;MUMBAI&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="Amitabh Bachchan" href="/topic/Amitabh+Bachchan" &gt;Amitabh Bachchan&lt;/a&gt;, one of &lt;a title="India" href="/topic/India" &gt;India&lt;/a&gt;'s top actors, whose disciplined, teetotaling life is somewhat rare in &lt;a title="Bollywood" href="/topic/Bollywood" &gt;Bollywood&lt;/a&gt;, has said his liver has been partially destroyed by cirrhosis, requiring constant medical attent...</summary><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="British Broadcasting Corporation"></category><category term="Reuters Group plc"></category><category term="Mumbai"></category><category term="South Asia"></category><category term="Amitabh Bachchan"></category><category term="Ben Kingsley"></category><category term="Bollywood"></category></entry><entry><title>India's Bachchan reveals serious liver condition</title><link href="http://liverdiseaseinfo.com/liver-diseases/indias-bachchan-reveals-liver-condition-915255a" rel="alternate"></link><updated>2010-04-25T15:15:46Z</updated><author><name>AFP Global Edition</name></author><id>tag:liverdiseaseinfo.com,2010-04-25:/liver-diseases/indias-bachchan-reveals-liver-condition-915255a</id><summary type="html">&lt;div&gt;&lt;p&gt;Veteran &lt;a title="Bollywood" href="/topic/Bollywood" &gt;Bollywood&lt;/a&gt; superstar &lt;a title="Amitabh Bachchan" href="/topic/Amitabh+Bachchan" &gt;Amitabh Bachchan&lt;/a&gt; on Sunday sought to reassure fans about his health after revealing he was suffering from cirrhosis of the liver and needed regular medical check-ups. Bachchan, a 67-year-old teetotaller, said 25 percent of his liver had been destroyed by the condition, which he said was the long-term result of a blood transfusion after an accident ...</summary><category term="Entertainment"></category><category term="Celebrity News"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="South Asia"></category><category term="Amitabh Bachchan"></category><category term="Aishwarya Rai"></category><category term="Bollywood"></category><category term="Blood Transfusion and Donation"></category></entry><entry><title>Pfizer ends trial of Sutent in liver cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-912894a" rel="alternate"></link><updated>2010-08-25T14:38:03Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-08-25:/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-912894a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; says &lt;a title="Sutent" href="/topic/Sutent" &gt;Sutent&lt;/a&gt; was not working better than Bayer's &lt;a title="Nexavar" href="/topic/Nexavar" &gt;Nexavar&lt;/a&gt; as a treatment for liver cancer&lt;/div&gt;&lt;div&gt;&lt;p&gt;Pfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer. Pfizer said patients who were treated with Sutent were not surviving as long as patients who were treated with a...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Sutent"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category></entry><entry><title>Down and Dirty</title><link href="http://liverdiseaseinfo.com/liver-diseases/dirty-905109a" rel="alternate"></link><updated>2010-04-15T21:15:24Z</updated><author><name>Men's Fitness</name></author><id>tag:liverdiseaseinfo.com,2010-04-15:/liver-diseases/dirty-905109a</id><summary type="html">&lt;div&gt;&lt;p&gt;Whenever I use the bathroom at work, I put down one of those paper seats on top of the bowl. Is this actually protecting me from anything or is it just there for mental comforts? And what kinds of diseases or sickness can you actually catch from a toilet seat? — J. Kahn, &lt;a title="Queens County" href="/topic/Queens+County" &gt;Queens, New York&lt;/a&gt;  I actually researched this question in 2004 when I had to use a portable toilet at a microbrew festival in &lt;a title="Virginia" href="/topic/Virg...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Men's Fitness Magazine"></category><category term="Sirius XM Radio Inc."></category><category term="Turner Field"></category></entry><entry><title>Jailed China activist Hu Jia may have cancer-wife</title><link href="http://liverdiseaseinfo.com/liver-diseases/jailed-china-activist-hu-jia-cancerwife-897220a" rel="alternate"></link><updated>2010-04-08T02:45:05Z</updated><author><name>Reuters US Online Report World News</name></author><id>tag:liverdiseaseinfo.com,2010-04-08:/liver-diseases/jailed-china-activist-hu-jia-cancerwife-897220a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Beijing" href="/topic/Beijing" &gt;BEIJING&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Imprisoned Chinese AIDS activist &lt;a title="Hu Jia" href="/topic/Hu+Jia" &gt;Hu Jia&lt;/a&gt; is suffering from a serious disease, possibly liver cancer, his wife said on Thursday after making a formal appeal to security forces to release him on medical parole. Hu's mother saw a suspected diagnosis of liver cancer on a consent form she was asked to sign when he was ta...</summary><category term="Criminal Sentencing and Punishment"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Contagious and Infectious Diseases"></category><category term="HIV and AIDS"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Reuters Group plc"></category><category term="Tibet"></category><category term="East Asia"></category><category term="Hu Jia"></category><category term="Zeng Jinyan"></category></entry><entry><title>Curry ingredient shows promise against liver damage</title><link href="http://liverdiseaseinfo.com/liver-diseases/curry-ingredient-shows-promise-liver-damage-883542a" rel="alternate"></link><updated>2010-03-23T20:00:36Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-03-23:/liver-diseases/curry-ingredient-shows-promise-liver-damage-883542a</id><summary type="html">&lt;div&gt;&lt;p&gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A compound found in the common curry spice turmeric appears to delay the liver damage that eventually causes cirrhosis, scientists said on Wednesday. In a study published in Gut, a &lt;a title="BMJ Publishing Group Ltd." href="/topic/BMJ+Publishing+Group+Ltd." &gt;British Medical Journal&lt;/a&gt; title, Austrian scientists found that feeding the compound curcumin to mice reduced the types of inflammation that can c...</summary><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Sciences"></category><category term="Reuters Group plc"></category><category term="Central Europe"></category><category term="Michael Trauner"></category><category term="Kate Kelland"></category></entry><entry><title>New research finds promising treatment for hepatitis C</title><link href="http://liverdiseaseinfo.com/liver-diseases/new-research-finds-promising-treatment-hepatitis-825720a" rel="alternate"></link><updated>2010-04-16T07:28:51Z</updated><author><name>AFP Global Edition</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/new-research-finds-promising-treatment-hepatitis-825720a</id><summary type="html">&lt;div&gt;&lt;p&gt;US scientists have discovered a way to block replication of the hepatitis C virus, potentially leading to better treatment for the top cause of liver cancer in the &lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt;, a study said Wednesday. In vitro experiments identified a protein that is essential to the reproductive cycle of the hepatitis C virus (HCV), the researchers said. An altered synthetic version of the protein was found to destroy the virus' ability to repl...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Jeffrey Glenn"></category><category term="Center for Hepatitis and Liver Tissue"></category></entry><entry><title>Team finds potential path for hepatitis C drugs</title><link href="http://liverdiseaseinfo.com/liver-diseases/team-finds-potential-path-hepatitis-drugs-825621a" rel="alternate"></link><updated>2010-04-16T07:28:58Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/team-finds-potential-path-hepatitis-drugs-825621a</id><summary type="html">&lt;div&gt;&lt;p&gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - U.S. scientists have identified a new class of drugs that appear to block the hepatitis C virus from replicating in laboratory experiments, researchers said on Wednesday. The team discovered activity within a key protein of the hepatitis C virus (HCV) essential for the virus to reproduce, they reported in the online journal Science Translational Medicine. The researchers also identified small molecul...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Sciences"></category><category term="Reuters Group plc"></category><category term="Jeffrey Glenn"></category><category term="Stanford's Center for Hepatitis and Liver Tissue Engineering"></category></entry><entry><title>Correction: Vertex Hepatitis C Drug</title><link href="http://liverdiseaseinfo.com/liver-diseases/correction-vertex-hepatitis-drug-816056a" rel="alternate"></link><updated>2010-04-16T07:40:03Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/correction-vertex-hepatitis-drug-816056a</id><summary type="html">&lt;div id="subtitle"&gt;Correction: Vertex Hepatitis C Drug&lt;/div&gt;&lt;div&gt;&lt;p&gt;In a story Jan. 11 about &lt;a title="Vertex Pharmaceuticals Inc." href="/topic/Vertex+Pharmaceuticals+Inc." &gt;Vertex Pharmaceuticals Inc.&lt;/a&gt; and its hepatitis C drug, &lt;a title="The Associated Press" href="/topic/The+Associated+Press" &gt;The Associated Press&lt;/a&gt; misstated when the company will seek regulatory approval for the drug. Approval will be requested in the second half of 2010, not 2009.&lt;/p&gt;&lt;img src="http://admatch-syndicatio...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="The Associated Press"></category><category term="Vertex Pharmaceuticals Inc."></category></entry><entry><title>Correction: Vertex Hepatis C Drug</title><link href="http://liverdiseaseinfo.com/liver-diseases/correction-vertex-hepatis-drug-816046a" rel="alternate"></link><updated>2010-04-16T07:40:03Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/correction-vertex-hepatis-drug-816046a</id><summary type="html">&lt;div id="subtitle"&gt;Correction: Vertex Hepatis C Drug&lt;/div&gt;&lt;div&gt;&lt;p&gt;In a story Jan. 11 about &lt;a title="Vertex Pharmaceuticals Inc." href="/topic/Vertex+Pharmaceuticals+Inc." &gt;Vertex Pharmaceuticals Inc.&lt;/a&gt; and its hepatitis C drug, &lt;a title="The Associated Press" href="/topic/The+Associated+Press" &gt;The Associated Press&lt;/a&gt; misstated when the company will seek regulatory approval for the drug. Approval will be requested in the second half of 2010, not 2009.&lt;/p&gt;&lt;img src="http://admatch-syndication....</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="The Associated Press"></category><category term="Vertex Pharmaceuticals Inc."></category></entry><entry><title>Vertex to ask for telaprevir OK later in 2010</title><link href="http://liverdiseaseinfo.com/liver-diseases/vertex-telaprevir-201-812339a" rel="alternate"></link><updated>2010-04-16T07:44:31Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/vertex-telaprevir-201-812339a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Vertex Pharmaceuticals Inc." href="/topic/Vertex+Pharmaceuticals+Inc." &gt;Vertex Pharmaceuticals&lt;/a&gt; to seek regulatory OK for telaprevir hepatitis drug in 2nd half of 2010&lt;/div&gt;&lt;div&gt;&lt;p&gt;Biotechnology company Vertex Pharmaceuticals Inc. said Monday it plans to seek regulatory approval of the experimental hepatitis C drug telaprevir as scheduled during the second half of 2009. Telaprevir is one of several potential hepatitis C treatments in development. If approved, it c...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Vertex Pharmaceuticals Inc."></category></entry><entry><title>Achillion shares rise on hepatitis C drug data</title><link href="http://liverdiseaseinfo.com/liver-diseases/achillion-shares-rise-hepatitis-drug-data-781961a" rel="alternate"></link><updated>2010-04-16T08:21:03Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/achillion-shares-rise-hepatitis-drug-data-781961a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Achillion Pharmaceuticals Inc." href="/topic/Achillion+Pharmaceuticals+Inc." &gt;Achillion Pharmaceuticals&lt;/a&gt; shares rise on positive early-stage hepatitis C drug data&lt;/div&gt;&lt;div&gt;&lt;p&gt;Shares of Achillion Pharmaceuticals Inc. surged Wednesday after the company said its hepatitis C drug candidate showed positive "proof-of-concept" results, while meeting safety and tolerability goals in an early-stage study. The stock gained $1.12, or 52 percent, to $3.27 in afternoon tradin...</summary><category term="Clinical Trials"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Vertex Pharmaceuticals Inc."></category><category term="InterMune Inc."></category><category term="Liisa Bayko"></category><category term="JMP Group Inc."></category><category term="Pharmasset Inc."></category><category term="Achillion Pharmaceuticals Inc."></category><category term="New Haven (Connecticut)"></category></entry><entry><title>Georgia congressman has hepatitis C</title><link href="http://liverdiseaseinfo.com/liver-diseases/georgia-congressman-hepatitis-769405a" rel="alternate"></link><updated>2010-04-16T08:35:55Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/georgia-congressman-hepatitis-769405a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Hank Johnson" href="/topic/Hank+Johnson" &gt;Rep. Hank Johnson&lt;/a&gt; of &lt;a title="Georgia" href="/topic/Georgia" &gt;Georgia&lt;/a&gt; has hepatitic C, says treatment going well&lt;/div&gt;&lt;div&gt;&lt;p&gt;Rep. Hank Johnson, D-Ga., has revealed that he has hepatitis C, a serious liver disease that can lead to fatal complications such as cancer or liver failure. In recent months, the 55-year-old Johnson has appeared thin and frail. The two-term &lt;a title="Atlanta" href="/topic/Atlanta" &gt;Atlanta&lt;/a...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Hank Johnson"></category></entry><entry><title>Researchers develop new hepatitis C treatment</title><link href="http://liverdiseaseinfo.com/liver-diseases/researchers-develop-new-hepatitis-treatment-764157a" rel="alternate"></link><updated>2010-04-16T08:42:02Z</updated><author><name>AFP Global Edition</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/researchers-develop-new-hepatitis-treatment-764157a</id><summary type="html">&lt;div&gt;&lt;p&gt;An experimental treatment targeting hepatitis C was able to inhibit replication of the virus in the bloodstream of chimpanzees and could treat chronic infections in humans, a new study said Thursday. The treatment works by inhibiting a molecule that helps hepatitis C virus replicate, according to scientists at the Southwest &lt;a title="Foundation for Biomedical Research" href="/topic/Foundation+for+Biomedical+Research" &gt;Foundation for Biomedical Research&lt;/a&gt; (SFBR), who said the drug conti...</summary><category term="Clinical Trials"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Social and Behavioral Sciences"></category><category term="Anthropology"></category><category term="Biological Anthropology"></category><category term="Primatology"></category><category term="Nature and the Environment"></category><category term="Wildlife"></category><category term="Mammals"></category><category term="Robert Lanford"></category><category term="Santaris Pharma A/S"></category></entry><entry><title>Pharmasset: hepatitis C drug trial will continue</title><link href="http://liverdiseaseinfo.com/liver-diseases/pharmasset-hepatitis-drug-trial-continue-752219a" rel="alternate"></link><updated>2010-08-25T14:10:41Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-08-25:/liver-diseases/pharmasset-hepatitis-drug-trial-continue-752219a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Pharmasset Inc." href="/topic/Pharmasset+Inc." &gt;Pharmasset&lt;/a&gt; says Roche will continue enrolling subjects in RG7128 trial after committee review&lt;/div&gt;&lt;div&gt;&lt;p&gt;Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C. An independent committee reviewed data from the first 100 subjects enrolled in the midstage study, which compares a combination of RG7128 and standa...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Western Europe"></category><category term="Pharmasset Inc."></category></entry><entry><title>Vertex drug helps hepatitis C patients</title><link href="http://liverdiseaseinfo.com/liver-diseases/vertex-drug-helps-hepatitis-patients-720821a" rel="alternate"></link><updated>2010-04-16T09:35:01Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/vertex-drug-helps-hepatitis-patients-720821a</id><summary type="html">&lt;div id="subtitle"&gt;Vertex says most patients on telaprevir for hepatitis C had undetectable virus levels in trial&lt;/div&gt;&lt;div&gt;&lt;p&gt;&lt;a title="Vertex Pharmaceuticals Inc." href="/topic/Vertex+Pharmaceuticals+Inc." &gt;Vertex Pharmaceuticals Inc.&lt;/a&gt; said Wednesday its hepatitis C treatment telaprevir created an immune system response to the virus in patients who had not been helped by other drugs. The results came from a midstage trial of the experimental drug. Vertex said a majority of patients who had ...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Vertex Pharmaceuticals Inc."></category></entry><entry><title>Coffee may slow liver damage from hepatitis</title><link href="http://liverdiseaseinfo.com/liver-diseases/coffee-slow-liver-damage-hepatitis-718175a" rel="alternate"></link><updated>2010-04-16T09:37:54Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/coffee-slow-liver-damage-hepatitis-718175a</id><summary type="html">&lt;div&gt;&lt;p&gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - A few cups of coffee everyday may help slow the progression of liver disease associated with long-term infection with the hepatitis C virus, a new study hints. Researchers found that among 766 patients with hepatitis C-related liver damage, those who drank three or more cups of coffee per day were 53 percent less likely than non-drinkers to see their liver disease progress over four years. The f...</summary><category term="Food and Cooking"></category><category term="Beverages"></category><category term="Coffee"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Reuters Group plc"></category><category term="Neal Freedman"></category></entry><entry><title>A few coffees a day keep liver disease at bay: study</title><link href="http://liverdiseaseinfo.com/liver-diseases/coffees-day-liver-disease-bay-study-713076a" rel="alternate"></link><updated>2010-04-16T09:42:57Z</updated><author><name>AFP Global Edition</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/coffees-day-liver-disease-bay-study-713076a</id><summary type="html">&lt;div&gt;&lt;p&gt;Researchers in the &lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt; have found another good reason to go to the local espresso bar: several cups of coffee a day could halt the progression of liver disease, a study showed Wednesday. Sufferers of chronic hepatitis C and advanced liver disease who drank three or more cups of coffee per day slashed their risk of the disease progressing by 53 percent compared to patients who drank no coffee, the study led by &lt;a title="N...</summary><category term="Food and Cooking"></category><category term="Beverages"></category><category term="Coffee"></category><category term="Tea"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Hepatitis Antiviral"></category><category term="Neal Freedman"></category></entry><entry><title>Surgery tech in hepatitis C cases pleads guilty</title><link href="http://liverdiseaseinfo.com/liver-diseases/surgery-tech-hepatitis-cases-pleads-guilty-683690a" rel="alternate"></link><updated>2010-04-16T10:08:05Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/surgery-tech-hepatitis-cases-pleads-guilty-683690a</id><summary type="html">&lt;div id="subtitle"&gt;Colorado surgery technician pleads guilty in hepatitis C cases, will get 20 years in prison&lt;/div&gt;&lt;div&gt;&lt;p&gt;A surgery technician who infected at least 16 hospital patients with hepatitis C and may have exposed thousands more pleaded guilty to some charges Friday in an agreement that includes a 20-year prison term. Kristen &lt;a title="Diane Parker" href="/topic/Diane+Parker" &gt;Diane Parker&lt;/a&gt;, 26, had pleaded not guilty to the 42-count indictment but in the plea agreement Friday ack...</summary><category term="Criminal Sentencing and Punishment"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Mount Kisco"></category><category term="Robert Blackburn"></category><category term="Rose Medical Center"></category><category term="Diane Parker"></category><category term="Gregory Graf"></category><category term="Northern Westchestern Hospital"></category><category term="Kristen Parker"></category><category term="Jeffrey Sweetin"></category></entry><entry><title>UK's NICE again rejects Bayer liver cancer drug</title><link href="http://liverdiseaseinfo.com/liver-diseases/uks-nice-rejects-bayer-liver-cancer-drug-661382a" rel="alternate"></link><updated>2010-04-16T10:26:10Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/uks-nice-rejects-bayer-liver-cancer-drug-661382a</id><summary type="html">&lt;div&gt;&lt;p&gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt;'s healthcare cost-effectiveness watchdog has again rejected &lt;a title="Bayer AG" href="/topic/Bayer+AG" &gt;Bayer&lt;/a&gt;'s drug &lt;a title="Nexavar" href="/topic/Nexavar" &gt;Nexavar&lt;/a&gt; for treating liver cancer on the state health service, despite a revised charging scheme from the company. Wednesday's decision is a setback for Bayer and its partn...</summary><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Western Europe"></category><category term="The Balkans"></category><category term="Reuters Group plc"></category><category term="Romania"></category><category term="Nice (France)"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Southern Europe"></category><category term="Nexavar"></category><category term="Nicole Farmer"></category></entry><entry><title>U.S. probes Roche, Glaxo diet drug over liver injury</title><link href="http://liverdiseaseinfo.com/liver-diseases/probes-roche-glaxo-diet-drug-liver-injury-643067a" rel="alternate"></link><updated>2010-04-16T10:40:21Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/probes-roche-glaxo-diet-drug-liver-injury-643067a</id><summary type="html">&lt;div&gt;&lt;p&gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - U.S. health officials are reviewing reports of liver injury in people who took &lt;a title="F. Hoffman-La Roche Ltd." href="/topic/F.+Hoffman-La+Roche+Ltd." &gt;Roche Holding AG&lt;/a&gt;'s weight loss drug &lt;a title="Xenical" href="/topic/Xenical" &gt;Xenical&lt;/a&gt; or the over-the-counter version sold by &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;. The &lt;a title="Food and Drug...</summary><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Reuters Group plc"></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Lisa Richwine"></category><category term="Ransdell Pierson"></category><category term="Krensavage Asset Management LLC"></category><category term="New York Stock Exchange"></category></entry><entry><title>FDA probes liver damage with weight loss pill alli</title><link href="http://liverdiseaseinfo.com/liver-diseases/fda-probes-liver-damage-weight-loss-pill-alli-643037a" rel="alternate"></link><updated>2010-04-16T10:40:23Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/fda-probes-liver-damage-weight-loss-pill-alli-643037a</id><summary type="html">&lt;div id="subtitle"&gt;FDA probes liver damage with alli, only nonprescription weight loss drug approved in US&lt;/div&gt;&lt;div&gt;&lt;p&gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency. Regulators said Monday they have received more than 30 reports of liver damage in patients taking alli and &lt;a title="Xenical" h...</summary><category term="Weight Loss"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Western Europe"></category><category term="London (England)"></category><category term="Debbie Bolding"></category></entry><entry><title>Anadys says hepatitis C drug shows potential</title><link href="http://liverdiseaseinfo.com/liver-diseases/anadys-hepatitis-drug-shows-potential-627797a" rel="alternate"></link><updated>2010-08-25T14:14:48Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-08-25:/liver-diseases/anadys-hepatitis-drug-shows-potential-627797a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Anadys Pharmaceuticals Inc." href="/topic/Anadys+Pharmaceuticals+Inc." &gt;Anadys Pharmaceuticals&lt;/a&gt; says hepatitis C drug candidate shows potential in early study&lt;/div&gt;&lt;div&gt;&lt;p&gt;Anadys Pharmaceuticals Inc. said Tuesday its hepatitis C drug candidate ANA-773 could be extremely effective at treating the diseases. The statement is based on early-stage study data, which is only typically good for studying safety. But, the company said early-stage, or Phase I, data showed th...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Clinical Trials"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Anadys Pharmaceuticals Inc."></category><category term="Steve Worland"></category></entry><entry><title>Surgery tech pleads not guilty in hepatitis case</title><link href="http://liverdiseaseinfo.com/liver-diseases/surgery-tech-pleads-guilty-hepatitis-case-622665a" rel="alternate"></link><updated>2010-04-16T10:57:24Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/surgery-tech-pleads-guilty-hepatitis-case-622665a</id><summary type="html">&lt;div id="subtitle"&gt;Colo. surgery tech linked to hepatitis cases pleads not guilty to painkiller tampering charges&lt;/div&gt;&lt;div&gt;&lt;p&gt;A surgery technician accused of swapping her dirty syringes for ones filled with powerful painkillers meant for patients, possibly exposing thousands of people to hepatitis C, pleaded not guilty to federal charges Thursday. Prosecutors claim &lt;a title="Kristen Diane Parker" href="/topic/Kristen+Diane+Parker" &gt;Kristen Diane Parker&lt;/a&gt;, 26, is linked to at least 19 cases of...</summary><category term="Trials"></category><category term="Criminal Trials"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Harris County"></category><category term="Mark Vincent"></category><category term="Mount Kisco"></category><category term="Johnson Space Center"></category><category term="Rose Medical Center"></category><category term="Kristen Diane Parker"></category><category term="Gregory Graf"></category><category term="Christus St. John Hospital"></category><category term="Audubon Surgery Center"></category><category term="Northern Westchestern Hospital"></category><category term="Jeffrey Hammond"></category></entry><entry><title>Anadys rockets after FDA approves trial design</title><link href="http://liverdiseaseinfo.com/liver-diseases/anadys-rockets-fda-approves-trial-design-615140a" rel="alternate"></link><updated>2010-08-25T14:15:17Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-08-25:/liver-diseases/anadys-rockets-fda-approves-trial-design-615140a</id><summary type="html">&lt;div id="subtitle"&gt;Anadys Pharma says &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;FDA&lt;/a&gt; approved mid stage study design for ANA598, and shares advance&lt;/div&gt;&lt;div&gt;&lt;p&gt;Shares of &lt;a title="Anadys Pharmaceuticals Inc." href="/topic/Anadys+Pharmaceuticals+Inc." &gt;Anadys Pharmaceuticals Inc.&lt;/a&gt; climbed Friday after the company said regulators approved the design of a study of a potential hepatitis C treatment. In morning trading, Anadys stock jumped $1.32, or 73...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Thomas Weisel Partners Group Inc."></category><category term="Anadys Pharmaceuticals Inc."></category><category term="Stephen Willey"></category></entry><entry><title>Anadys gets FDA OK to start hepatitis C study</title><link href="http://liverdiseaseinfo.com/liver-diseases/anadys-fda-start-hepatitis-study-614201a" rel="alternate"></link><updated>2010-04-16T11:04:32Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/anadys-fda-start-hepatitis-study-614201a</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Anadys Pharmaceuticals Inc." href="/topic/Anadys+Pharmaceuticals+Inc." &gt;Anadys Pharmaceuticals&lt;/a&gt; gets FDA clearance to begin study on hepatitis C therapy&lt;/div&gt;&lt;div&gt;&lt;p&gt;Anadys Pharmaceuticals Inc. said Thursday the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; cleared the company's plan for a midstage study on a potential combination therapy for hepatitis C. The combination includes the drug candi...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Anadys Pharmaceuticals Inc."></category></entry><entry><title>Both hepatitis C drugs work about the same: study</title><link href="http://liverdiseaseinfo.com/liver-diseases/hepatitis-drugs-work-study-604079a" rel="alternate"></link><updated>2010-04-16T11:12:17Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/hepatitis-drugs-work-study-604079a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday. The findings, from a 3,000-patient comparative effectiveness study, are meant to help guide doctors' decisions about which treatments work best -- an idea at the center of Present &lt;a title="Barack Obama" href="/topic...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="The New England Journal of Medicine"></category><category term="Reuters Group plc"></category><category term="Barack Obama"></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Vertex Pharmaceuticals Inc."></category><category term="Maggie Fox"></category><category term="Pegasys"></category><category term="Andrew Muir"></category><category term="Mark Sulkowski"></category></entry><entry><title>Another hepatitis case linked to Colorado hospital</title><link href="http://liverdiseaseinfo.com/liver-diseases/hepatitis-case-linked-colorado-hospital-595575a" rel="alternate"></link><updated>2010-04-16T11:19:29Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/hepatitis-case-linked-colorado-hospital-595575a</id><summary type="html">&lt;div id="subtitle"&gt;Another hepatitis case linked to &lt;a title="Colorado" href="/topic/Colorado" &gt;Colorado&lt;/a&gt; hospital where surgery tech worked; total now 11&lt;/div&gt;&lt;div&gt;&lt;p&gt;Another hepatitis C case has been linked to a &lt;a title="Denver" href="/topic/Denver" &gt;Denver&lt;/a&gt; hospital where an infected surgery technician is accused of swapping her dirty syringes for ones filled with a powerful painkiller meant for patients. Colorado health officials said Friday that 11 cases are now linked to &lt;a title="R...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Rose Medical Center"></category><category term="Kristen Diane Parker"></category><category term="Audubon Surgery Center"></category></entry><entry><title>NY hospital warns of possible hepatitis exposures</title><link href="http://liverdiseaseinfo.com/liver-diseases/ny-hospital-warns-hepatitis-exposures-595685a" rel="alternate"></link><updated>2010-04-16T11:19:24Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/ny-hospital-warns-hepatitis-exposures-595685a</id><summary type="html">&lt;div id="subtitle"&gt;NY hospital warns of possible hepatitis exposure from tech charged in &lt;a title="Colorado" href="/topic/Colorado" &gt;Colorado&lt;/a&gt; cases&lt;/div&gt;&lt;div&gt;&lt;p&gt;A hospital in &lt;a title="New York" href="/topic/New+York" &gt;New York&lt;/a&gt; state is notifying about 2,800 patients of possible exposure to hepatitis C after learning that a former employee is suspected of exposing nearly 6,000 patients in Colorado to the disease. The &lt;a title="New York State Department of Health" href="/topic/New+York+St...</summary><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Public Health Policy"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Mount Kisco"></category><category term="New York State Department of Health"></category><category term="Northern Westchester Hospital"></category><category term="Rose Medical Center"></category><category term="Audubon Ambulatory Surgery Center"></category><category term="Kristen Diane Parker"></category></entry><entry><title>Scrub tech causes major hepatitis scare in Colo.</title><link href="http://liverdiseaseinfo.com/liver-diseases/scrub-tech-major-hepatitis-scare-colo-590949a" rel="alternate"></link><updated>2010-04-16T11:23:15Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/scrub-tech-major-hepatitis-scare-colo-590949a</id><summary type="html">&lt;div id="subtitle"&gt;Painkiller-addicted scrub tech causes hepatitis scare in Colo, unnerving thousands of patients&lt;/div&gt;&lt;div&gt;&lt;p&gt;Kimberly Spencer's 9-year-old son went to &lt;a title="Audubon Ambulatory Surgery Center" href="/topic/Audubon+Ambulatory+Surgery+Center" &gt;Audubon Ambulatory Surgery Center&lt;/a&gt; last month for what was supposed to be a routine surgery. The rambunctious child stuck a BB in his ear and doctors had to operate to remove it. What happened next shocked the family. They were notifi...</summary><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Liver Diseases"></category><category term="Denver Police Department"></category><category term="Ned Calonge"></category><category term="Rose Medical Center"></category><category term="Audubon Ambulatory Surgery Center"></category><category term="Kristen Diane Parker"></category><category term="Gregory Graf"></category><category term="Eric Steiner"></category></entry><entry><title>World Hepatitis Day - Photocall</title><link href="http://liverdiseaseinfo.com/photo/world-hepatitis-day-photocall-1205355p" rel="alternate"></link><updated>2010-04-07T15:00:49Z</updated><author><name>Getty Images</name></author><id>tag:liverdiseaseinfo.com,2010-04-07:/photo/world-hepatitis-day-photocall-1205355p</id><summary type="html">LONDON, &lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;ENGLAND&lt;/a&gt; - MAY 18:  &lt;a title="Ken Livingstone" href="/topic/Ken+Livingstone" &gt;Ken Livingstone&lt;/a&gt;, former Mayor of London, poses for photographs after getting tested for Hepatitis B and Hepatitis C, to promote getting tested ahead of World Hepatitis Day 2009 (19th May 2009), on the first ever "Get Tested!" bus at &lt;a title="Leicester Square" href="/topic/Leicester+Square" &gt;Leicester Square&lt;/a&gt; on May 18, 2009 in &lt;a title="London (...</summary><category term="Politics"></category><category term="Local Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="British Politics"></category><category term="Contagious and Infectious Diseases"></category><category term="Hepatitis"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Western Europe"></category><category term="Getty Images Inc."></category><category term="Ken Livingstone"></category><category term="Leicester Square"></category><category term="London (England)"></category></entry><entry><title>Octuplets</title><link href="http://liverdiseaseinfo.com/photo/octuplets-600718p" rel="alternate"></link><updated>2010-04-13T20:54:30Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-13:/photo/octuplets-600718p</id><summary type="html">This undated picture provided by &lt;a title="NBC Universal Inc." href="/topic/NBC+Universal+Inc." &gt;NBC News&lt;/a&gt; shows Jeremiah, one of the octuplets &lt;a title="Nadya Suleman" href="/topic/Nadya+Suleman" &gt;Nadya Suleman&lt;/a&gt; gave birth to on Jan. 26, 2009. He is being treated with light for jaundice. (AP Photo/NBC NEWS)
&lt;div id="copyright"&gt;&lt;div&gt;
        Copyright 2009  &lt;a href="http://www.ap.org"&gt;AP News&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;...</summary><category term="Media"></category><category term="Television"></category><category term="TV News Shows"></category><category term="Family"></category><category term="Parenting"></category><category term="Pregnancy and Childbirth"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="NBC Universal Inc."></category><category term="Twins and Multiples"></category><category term="Nadya Suleman"></category></entry></feed>